Human Molecular Genetics Advance Access originally published online on February 9, 2005
Human Molecular Genetics 2005 14(7):885-892; doi:10.1093/hmg/ddi081
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation
1Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA and 2Cardiovascular Division, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA
* To whom correspondence should be addressed at: 954 BRB II, 421 Curie Boulevard, Philadelphia, PA 19104, USA. Tel: +1 2158988731; Fax: +1 2155739306; Email: epsteinj{at}mail.med.upenn.edu
Received December 14, 2004; Accepted February 1, 2005
DiGeorge syndrome (DGS) is the most common human chromosomal deletion syndrome and is frequently associated with deletions on chromosome 22q11. Approximately 17% of patients with the phenotypic features of this syndrome have no detectable genomic deletion. Animal studies using mouse models have implicated Tbx1 as a critical gene within the commonly deleted region, and several mutations in TBX1 have been identified recently in non-deleted patients, including missense and frameshift mutations. The mechanisms by which these mutations cause disease have remained unclear. We have identified a previously unrecognized and novel nuclear localization signal (NLS) at the C-terminus of Tbx1 that is deleted by the 1223delC mutation, thus explaining the mechanism of disease in these patients. This NLS is conserved across species, among a subfamily of T-box proteins including Brachyury and Tbx10, and among additional nuclear proteins. By providing functional data to indicate loss-of-function produced by the 1223delC TBX1 mutation, our results provide strong support for the conclusion that TBX1 mutations can cause DGS in humans.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Kulisz and H.-G. Simon An Evolutionarily Conserved Nuclear Export Signal Facilitates Cytoplasmic Localization of the Tbx5 Transcription Factor Mol. Cell. Biol., March 1, 2008; 28(5): 1553 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince UV-mediated Regulation of the Anti-senescence Factor Tbx2 J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liang, Y. Sun, J. Schneider, J.-H. Ding, H. Cheng, M. Ye, S. Bhattacharya, A. Rearden, S. Evans, and J. Chen Pinch1 Is Required for Normal Development of Cranial and Cardiac Neural Crest-Derived Structures Circ. Res., March 2, 2007; 100(4): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paylor, B. Glaser, A. Mupo, P. Ataliotis, C. Spencer, A. Sobotka, C. Sparks, C.-H. Choi, J. Oghalai, S. Curran, et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome PNAS, May 16, 2006; 103(20): 7729 - 7734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Arnold, E. M. Braunstein, T. Ohyama, A. K. Groves, J. C. Adams, M. C. Brown, and B. E. Morrow Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients Hum. Mol. Genet., May 15, 2006; 15(10): 1629 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hiroi, H. Zhu, M. Lee, B. Funke, M. Arai, M. Itokawa, R. Kucherlapati, B. Morrow, T. Sawamura, and S. Agatsuma A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice PNAS, December 27, 2005; 102(52): 19132 - 19137. [Abstract] [Full Text] [PDF] |
||||




